PDE4 inhibitors 1998

被引：19

作者：

Norman, P

机构：

[1] 18 Pink Lane, Burnham

来源：

EXPERT OPINION ON THERAPEUTIC PATENTS | 1998年 / 8卷 / 07期

关键词：

asthma; PDE4; inhibitor; rheumatoid arthritis;

D O I：

10.1517/13543776.8.7.771

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The search for novel phosphodiesterase Type 4 (PDE4) inhibitors is currently one of the most active fields within the pharmaceutical industry. Recent progress in the clinical development of PDE4 inhibitors is reviewed. Particular emphasis is placed on those patents published within the past two years, highlighting the novel structural classes of PDE4 inhibitors reported.

引用

页码：771 / 784

页数：14

共 45 条

[31]

NIEMAN RB, 1998, AM J RESP CRIT CARE, V157

[32]

Norman P, 1997, DRUG NEWS PERSPECT, V10, P501

[33]

PASCAL Y, 1998, ACS

[34] Phosphodiesterase inhibitory properties of losartan.: Design and synthesis of new lead compounds [J].